Nov 02, 2021 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 FY '22 Earnings Conference Call of Sun Pharmaceutical Industries Limited. (Operator Instructions)
I would now like to hand the conference over to Mr. Nimish Desai, Head of Investor Relations. Thank you, and over to you, Mr. Desai.
Nimish Desai - Sun Pharmaceutical Industries Limited - Head of IR
Thank you. Good evening, and a warm welcome to our second quarter FY '22 earnings call. I'm Nimish from the Sun Pharma Investor Relations team. We hope you received the Q2 financials and the press release that was sent out earlier in the day. These are also available on our website. We have with us Mr. Dilip Shanghvi, Managing Director; Mr. C. S. Muralidharan, our CFO; Mr. Abhay Gandhi, CEO of North America; and Mr. Kirti Ganorkar, CEO of India Business. Today, the team will discuss performance highlights, update on strategies and respond to any questions that you may have.
As is usual, for the ease of discussion, we will look at consolidated financials. And just as a reminder, this call is being
Q2 2022 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Nov 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers